Subchronic (13-week) toxicity studies of N,N-dimethylaniline administered to Fischer 344 rats and B6C3F1 mice.

J Toxicol Environ Health

NIEHS-National Toxicology Program, Research Triangle Park, North Carolina 27709.

Published: March 1990

The subchronic toxicity of N,N-dimethylaniline (DMA) was studied by administration in corn oil by gavage at doses of 31.25, 62.5, 125, 250, 20, or 500 mg/kg body weight to groups of 10 male and 10 female F344 rats and B6C3F1 mice 5 d per week for 13 wk. No compound-related mortality was noted in either rats or mice. Significant decrease in body weight gain was observed in male rats at 250 and 500 mg/kg. The body weight gain of female rats and female mice was not adversely affected by the treatment. Clinical signs of toxicity (cyanosis and decrease in motor activity) occurred in both species and sexes in a dose-dependent fashion. Splenomegaly was observed in all treated groups of rats and mice, with the severity being dose-related. Microscopic examination revealed the presence of hemosiderin in the spleen, liver, testes, and kidney of treated rats and mice. Bone marrow hyperplasia and increased hematopoiesis in the spleen occurred in treated rats, and hematopoiesis was increased in the spleen and liver of treated mice. The severity of these lesions was dose-related. A no-observable-effect for mice was estimated at 31.25 mg/kg; however, a no-effect level was not reached in rats in this study. This suggests that rats are more sensitive than mice to the toxic effect of DMA.

Download full-text PDF

Source
http://dx.doi.org/10.1080/15287399009531373DOI Listing

Publication Analysis

Top Keywords

body weight
12
rats mice
12
rats
10
mice
9
rats b6c3f1
8
b6c3f1 mice
8
250 500
8
500 mg/kg
8
mg/kg body
8
weight gain
8

Similar Publications

A synchronized event-cue feedback loop integrating a 3D printed wearable flexible sensor-tactor platform.

Biosens Bioelectron

January 2025

Department of Physics, Virginia Commonwealth University, Richmond, VA, 23284, USA; Institute for Sustainable Energy and Environment, Virginia Commonwealth University, Richmond, VA, 23284, USA. Electronic address:

Wearable devices designed for the somatosensory system aim to provide event-cue feedback electronics and therapeutic stimulation to the peripheral nervous system. This prompts a neurological response that is relayed back to the central nervous system. Unlike virtual reality tools, these devices precisely target peripheral mechanoreceptors by administering specific stimuli.

View Article and Find Full Text PDF

Background: Nonweightbearing preoperative assessments avoid quadriceps contraction that tends to affect patellar motion and appear to be inaccurate in quantifying anatomic factors, which can lead to incorrect corrections and postoperative complications.

Questions/purposes: (1) Does the relationship of patellar axial malalignment and other anatomic factors change during weightbearing? (2) What anatomic factor was most strongly correlated with recurrent patellar dislocation during weightbearing?

Methods: This prospective, comparative, observational study recruited participants at our institution between January 2023 and September 2023. During this time, all patients with recurrent patellar dislocations received both weightbearing and nonweightbearing CT scans; control patients who received unilateral CT scans because of injuries or benign tumors received both weightbearing and nonweightbearing CT scans.

View Article and Find Full Text PDF

Background: The prevalence of stroke is high in both males and females, and it rises with age. Stroke often leads to sensor and motor issues, such as hemiparesis affecting one side of the body. Poststroke patients require torso stabilization exercises, but maintaining proper posture can be challenging due to their condition.

View Article and Find Full Text PDF

Background: Enhancing self-management in health care through digital tools is a promising strategy to empower patients with type 2 diabetes (T2D) to improve self-care.

Objective: This study evaluates whether the Greenhabit (mobile health [mHealth]) behavioral treatment enhances T2D outcomes compared with standard care.

Methods: A 12-week, parallel, single-blind randomized controlled trial was conducted with 123 participants (62/123, 50%, female; mean age 58.

View Article and Find Full Text PDF

Objective: To provide an updated synthesis on effects of glucagon-like peptide 1 receptor agonists (GLP-1 RAs) on weight, BMI, and waist circumference incorporating newer randomized controlled trials (RCTs), particularly in individuals with overweight or obesity.

Research Design And Methods: We systematically searched PubMed, Embase, and Cochrane Central Register of Controlled Trials (CENTRAL) for RCTs published from inception to 4 October 2024. The search was limited to RCTs evaluating the use of GLP-1 RAs for mean differences from baseline in weight, BMI, and waist circumference in adults with obesity or overweight with or without diabetes.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!